From: CCNI2 promotes the progression of human gastric cancer through HDGF
Features | No. of patients | CCNI2 expression | p value | |
---|---|---|---|---|
Low | High | |||
All patients | 93 | 50 | 43 | Â |
Age (years) | Â | Â | Â | 0.331 |
  < 64 | 44 | 26 | 18 |  |
   ≥ 64 | 49 | 24 | 25 |  |
Gender | Â | Â | Â | 0.465 |
  Male | 62 | 35 | 27 |  |
  Female | 31 | 15 | 16 |  |
T Infiltrate | Â | Â | Â | 0.201 |
  T1 | 6 | 4 | 2 |  |
  T2 | 12 | 9 | 3 |  |
  T3 | 55 | 27 | 28 |  |
  T4 | 20 | 10 | 10 |  |
Lymphatic metastasis (N) |  |  |  | 0.475 |
  N0 | 14 | 12 | 2 |  |
  N1 | 14 | 6 | 8 |  |
  N2 | 20 | 7 | 13 |  |
  N3 | 45 | 25 | 20 |  |
Stage | Â | Â | Â | 0.020 |
  I | 5 | 4 | 1 |  |
  II | 22 | 17 | 5 |  |
  III | 63 | 26 | 37 |  |
  IV | 3 | 3 | 0 |  |
Tumor size | Â | Â | Â | 0.960 |
   < 5 cm | 38 | 20 | 18 |  |
   ≥ 5 cm | 48 | 25 | 23 |  |
Lymph node positive | Â | Â | Â | 0.911 |
   ≤ 6 | 47 | 25 | 22 |  |
   > 6 | 46 | 25 | 21 |  |
Vessel carcinoma embolus | Â | Â | Â | 0.879 |
  0 | 15 | 8 | 7 |  |
  1 | 54 | 30 | 24 |  |
Nerve tumor infiltrates | Â | Â | Â | 0.884 |
  0 | 21 | 10 | 11 |  |
  1 | 18 | 9 | 9 |  |
Expression of CD34 | Â | Â | Â | 0.888 |
  No | 10 | 6 | 4 |  |
  Yes | 32 | 20 | 12 |  |
Expression of EGFR | Â | Â | Â | 0.274 |
  No | 69 | 38 | 31 |  |
  Yes | 13 | 5 | 8 |  |
Expression of VEGF | Â | Â | Â | 0.025* |
    No | 39 | 26 | 13 |  |
  Yes | 43 | 18 | 25 |  |
Expression of CDX2 | Â | Â | Â | 0.202 |
  No | 11 | 8 | 3 |  |
  Yes | 73 | 38 | 35 |  |
Expression of Her2 | Â | Â | Â | 0.316 |
  No | 64 | 32 | 32 |  |
  Yes | 19 | 12 | 7 |  |